 PARIS and CAMBRIDGE, Mass., July 08, 2021 GLOBE NEWSWIRE -- Biophytis SA Nasdaq CM: BPTS, Euronext Growth Paris: ALBPS, Biophytis or the company, a clinical-stage biotechnology company focused on the development of therapeutics that are aimed at slowing the degenerative processes associated with aging and improving functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19, today announces the strengthening of its leadership teams with three new appointments of highly experienced healthcare executives. 